Advisor Group Holdings, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 25,115 shares of AUPH stock, worth $239,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,115

Previous 10,846 131.56%

Holding current value

$239,848

Previous $61,000 201.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.32 - $7.33 $75,911 - $104,591	14,269 Added 131.56%	25,115 $184,000
Q2 2024 Aug 13, 2024	SELL	$4.81 - $5.78 $1,981 - $2,381	-412 Reduced 3.66%	10,846 $61,000
Q1 2024 May 10, 2024	SELL	$4.93 - $9.31 $26,365 - $49,789	-5,348 Reduced 32.21%	11,258 $56,000
Q4 2023 Feb 12, 2024	BUY	$7.13 - $9.49 $684 - $911	96 Added 0.58%	16,606 $149,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $21,857 - $34,515	2,813 Added 20.54%	16,510 $128,000
Q2 2023 Aug 10, 2023	BUY	$8.96 - $11.69 $53,437 - $69,719	5,964 Added 77.12%	13,697 $132,000
Q1 2023 May 12, 2023	SELL	$5.94 - $11.27 $22,233 - $42,183	-3,743 Reduced 32.62%	7,733 $84,000
Q4 2022 Feb 10, 2023	SELL	$4.11 - $8.14 $4,738 - $9,385	-1,153 Reduced 9.13%	11,476 $49,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $27,905 - $51,914	-4,190 Reduced 24.91%	12,629 $95,000
Q2 2022 Aug 10, 2022	SELL	$8.95 - $12.8 $14,982 - $21,427	-1,674 Reduced 9.05%	16,819 $168,000
Q1 2022 May 04, 2022	BUY	$10.05 - $22.48 $6,060 - $13,555	603 Added 3.37%	18,493 $228,000
Q3 2021 Nov 05, 2021	SELL	$10.93 - $23.55 $180,006 - $387,844	-16,469 Reduced 47.93%	17,890 $395,000
Q2 2021 Aug 02, 2021	BUY	$10.0 - $14.52 $149,460 - $217,015	14,946 Added 76.99%	34,359 $444,000
Q1 2021 May 13, 2021	SELL	$12.3 - $18.73 $319,529 - $486,567	-25,978 Reduced 57.23%	19,413 $253,000
Q4 2020 Feb 10, 2021	BUY	$12.94 - $16.05 $337,229 - $418,279	26,061 Added 134.82%	45,391 $628,000
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $30,337 - $38,318	2,300 Added 13.51%	19,330 $285,000
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $138,799 - $180,183	9,830 Added 136.53%	17,030 $277,000
Q1 2020 May 18, 2020	BUY	$11.34 - $21.46 $81,648 - $154,512	7,200 New	7,200 $104,000

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.36B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Aurinia Pharmaceuticals Inc. Transaction History